16
Views
4
CrossRef citations to date
0
Altmetric
Review

Quality of life issues following autologous bone marrow transplantation

&
Pages 129-146 | Published online: 09 Jan 2014

References

  • Fliedner MC. Psychosocial adaptation after bone marrow transplantation (BMT) (Meeting abstract). 0=1 NUTS. Forum 22(2), 360 (1995).
  • Haberman M. The meaning of cancer therapy: bone marrow transplantation as an exemplar of therapy. Semin. 0=1 Nuts. 11(1), 23–31 (1995).
  • Rodrigue JR, Boggs SR, Weiner RS, Behan JM. Mood, coping style and personality functioning among adult bone marrow transplant candidates. P.Tchosomatics 34 (2), 159–165 (1993).
  • Shuster GF, Steeves RII, Onega L, Richardson B. Coping patterns among bone marrow transplant patients: a hermeneutical inquiry. Cancer NUIN. 19 (4), 290–297 (1996).
  • Bush NE, Haberman M, Donaldson G, Sullivan KM. QoL of 125 adults surviving 6–28 years after bone marrow transplantation. Sci Med. 40(4), 479–490 (1995).
  • Curbow B, Somerfield MR, Baker F, Wingard JR, Legro MW. Personal changes, dispositional optimism and psychological adjustment to bone marrow transplantation. I Behavioral Merl 16 (5), 423–423 (1993).
  • Fromm K, Andrykowski MA, Hunt J. Positive and negative psychosocial sequelae of bone marrow transplantation: implications for QoL assessment. J. Behavioral Merl 19(3), 221–240 (1996).
  • Murphy KC, Jenkins PL, Whittaker JA. Psychosocial morbidity and survival in adult bone marrow transplant recipients-a follow-up study. Bone Marrow 7iamp1ant. 18(1), 199–201 (1996).
  • Somerfield MR, Curbow B, Wingard JR, Baker F, Fogarty LA. Coping with the physical and psychosocial sequelae of bone marrow transplantation among long-term survivors. Behavioral Med. 19 (2), 163–184 (1996). toASCO. ASCO Daily News, Wrap-up Issue. ASCO Online (1999). www.asco.org/prof/ adn/wu-plenary.htm
  • Weiss RB, Rifkin RM, Stewart FM et al. High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study. Lancet 355 (9208), 999–1003 (2000).
  • Vickers A, Christos P. Bezwoda: evidence of fabrication in original article. J. Clin. Oncol 18(15), 2933 (2000).
  • Gale RP, Park RE, Dubois R et al. Delphi- panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer. Clin. Transplant. 14(1), 32–41 (2000).
  • Brown E. ABMT and breast cancer: what have we learned? Physician Exec. 25(4), 86–88(1999).
  • Peters WP, Ross M, Vredenburgh JJ et al High dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. j Clin. 0=1 11(6), 1132–1143 (1993).
  • Hann DM, Garovoy N, Finkelstein B, Jacobsen PB, Azzarello LM, Fields KIK. Fatigue and QoL in breast cancer patients undergoing autologous stem cell transplantation: A longitudinal comparative study. .1. Pain Symptom Manage. 17 (5), 311–319 (1999).
  • Hann DM, Jacobsen PB, Martin SC, Kronish LE, Azzarello LM, Fields KIK. Fatigue in women treated with bone marrow transplantation for breast cancer: a comparison with women with no history of cancer. Support. Cam Cancer5(1), 44–52 (1997).
  • •Interesting analysis of the problem of fatigue in women with breast cancer using several in-depth measures of fatigue.
  • Winer EP, Lindley C, Hardee M etal. QoL in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support. Psychooncology 8,167–176 (1999).
  • Gaston-Johansson F, Fall-Dickson JM, Nanda J et al The effectiveness of the comprehensive coping strategy program on clinical outcomes in breast cancer autologous bone marrow transplantation. Cancer Nuts. 23(4), 277–285 (2000).
  • ••Report of an RCT evaluating a clinical intervention designed to help patients cope with ASCT.
  • Macquart-Moulin G, Viens P, Palangie T et al High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on QoL jeopardize feasibility and acceptability of treatment? J. Clin. 0=1 18(4), 754–764 (2000).
  • Carlson LE, Koski T, Gluck S. Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on QoL in the treatment of metastatic breast cancer. Bone Marrow Transplant. 27(9), 989–998 (2001).
  • McQuellon RP, Craven B, Russell GB et al QoL in breast cancer patients before and after autologous bone marrow transplantation. Bone Marrow Transplant. 18(3), 579–584 (1996).
  • Feigin R, Greenberg A, Ras H et al The psychosocial experience of women treated for breast cancer by high-dose chemotherapy supported by autologous stem cell transplant: A qualitative analysis of support groups. Rychooncology9,57–68 (2000).
  • Larsen J, Gardulf A, Nordstrom G, Bjorkstrand B, Ljungman P. Health-related QoL in women with breast cancer undergoing autologous stem-cell transplantation. Cancer Nuts. 19(5), 368–375 (1996).
  • Whedon M, Stearns D, Mills LE. QoL of long-term adult survivors of autologous bone marrow transplantation. 0=1 NUTS. Forum22(10), 1527–1535 (1995).
  • Knobel H, Loge JH, Nordoy T et al High level of fatigue in lymphoma patients treated with high dose therapy. J. Pain Symptom Manage. 19(6), 446–456 (2000).
  • Andrykowski MA, Greiner CB, Altmaier EM et al QoL following bone marrow transplantation: findings from a multicentre study. BE j Cancer71 (6), 1322–1329 (1995).
  • •Large sample from several centres comparing allo and auto patients postBMT on a number of standardized questionnaires.
  • Andrykowski MA, Cordova MJ, Hann DM, Jacobsen PB, Fields KK, Phillips G. Patients' psychosocial concerns following stem cell transplantation. Bone Marrow Transplant. 24(10), 1121–1129 (1999).
  • •Qualitative analysis of group therapy transcripts identifying major themes and issues confronting patients following ASCT.
  • Watson M, Wheatley K, Harrison GA et al Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone. Cancer 86 (7), 1231–1239 (1999).
  • ••Large recent study looking in much more depth at issues of sexuality postBMT, comparing allo, auto and CT groups.
  • Yano K, Kanie T, Okamoto S et al QoL in adult patients after stem cell transplantation. int." Hematol 71(3), 283–289 (2000).
  • Hjermstad M, Holte H, Evensen S, Payers P, Kaasa S. Do patients who are treated with stem cell transplantation have a health-related QoL comparable to the general population after 1 year? Bone Marrow Transplant. 24(8), 911–918 (1999).
  • Zittoun R, Suciu S, Watson M et al. QoL in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant. 20(4), 307–315 (1997).
  • •Interesting study comparing allo vs. auto vs. CT patients on a broad range of Q01_, dimensions including sexual functioning.
  • Vose JM, Kennedy BC, Bierman PJ, Kessinger A, Armitage JO. Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer 69,784–789 (1992).
  • Widows MR, Jacobsen PB, Fields KK. Relation of psychological vulnerability factors to posttraumatic stress disorder symptomatology in bone marrow transplant recipients. Psychosomatic Med. 62(6), 873–882 (2000).
  • Jenkins PL, Linington A, Whittaker JA. A retrospective study of psychosocial morbidity in bone marrow transplant recipients. PTchosomatics 32 (1), 65–71 (1991).
  • Fromm K, Andrykowski MA, Hunt J. Positive and negative psychosocial sequelae of bone marrow transplantation: implications for QoL assessment. Behavioral Merl 19(3), 221–240 (1996).
  • Kopp M, Schweigkofler H, Holzner B et al. Time after bone marrow transplantation as an important variable for QoL: results of a cross-sectional investigation using two different instruments for quality-of-life assessment. Ann. Hernatol 77(1-2), 27–32 (1998).
  • Bush NE, Donaldson GW, Haberman Dacanay R, Sullivan KM. Conditional and unconditional estimation of multidimensional QoL after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol. Blood Man ow 7iansplant. 6(5A), 576–591 (2000).
  • ••Good example of excellent methodology,using prospective longitudinal methods and conditional statistical analysis to determine Q01_, over 4 years in a large sample.
  • Fife BL, Huster GA, Cornetta KG, Kennedy VN, Akard LP, Broun ER. Longitudinal study of adaptation to the stress of bone marrow transplantation. Clin. Oncol 18(7), 1539–1549 (2000).
  • Zittoun R, Achard S, Ruszniewski M. Assessment of QoL during intensive chemotherapy or bone marrow transplantation. Rychooncology 8,64–73 (1999).
  • •Intervention study evaluation the provision of staff with Q01_, information about patients during hospitalization.
  • Meyers CA, Weitzner M, Byrne K, Valentine A, Champlin RE, Przepiorka D. Evaluation of the neurobehavioral functioning of patients before, during and after bone marrow transplantation. J. Clin. Oncol 12(4), 820–826 (1994).
  • •Study looking at cognitive function and its relation to long-term outcome.
  • Hjermstad MJ, Evensen SA, Kvaloy SO, Payers PM, Kaasa S. Health-related QoL 1 year after allogeneic or autologous stem-cell transplantation: a prospective study.j Clin. Oncol 17 (2), 706–718 (1999).
  • Broers S, Kaptein AA, Le Cessie S, Fibbe W Hengeveld MW. Psychological functioning and QoL following bone marrow transplantation: a 3-year follow-up study. /bosom. Res. 48(1), 11–21 (2000).
  • Ahles TA, Tope DM, Furstenberg C, Hann D, Mills L. Psychologic and neuropsychologic impact of autologous bone marrow transplantation. j Clin. Oncol 14(5), 1457–1462 (1996).
  • ••Study that looked at cognitive functionprospectively using a broad battery of standardized tests. Highlighted some serious problems in memory and cognition in ABMT patients.
  • Grassi L, Rosti G, Albertazzi L, Marangolo M. Psychological stress symptoms before and after autologous bone marrow transplantation in patients with solid tumors. Bone Marrow Transplant. 17(5), 843–847 (1996).
  • Gaston-Johansson F, Franco T, Zimmerman L. Pain and psychological distress in patients undergoing autologous bone marrow transplantation. Oncol Nuts. Forum19(1), 41–48 (1992).
  • Wettergren L, Langius A, Bjorkholm M, Bjorvell H. Post-traumatic stress symptoms in patients undergoing autologous stem cell transplantation. Acta Oncol 38(4), 475–480 (1999).
  • McQuellon RP, Russell GB, Rambo TD et al QoL and psychological distress of bone marrow transplant recipients: the 'time trajectory' to recovery over the first year. Bone Marivw 7iamplant. 21, 477–486 (1998).
  • •Interesting study of the trends in anxiety, depression and QoL over time through the treatment trajectory, using a large battery of standardized questionnaires.
  • Courneya KS, Keats MR, Turner AR. Physical exercise and QoL in cancer patients following high dose chemotherapy and autologous bone marrow transplantation. Psychooncology9, 127–136 (1999).
  • •Study looking at the relationships between exercise during hospitalization and recovery from ABMT.
  • Andrykowski MA, McQuellon RR Bone Marrow Transplantation. In: Psycho-oncology Holland JC (Ed.) Oxford University Press, New York, NY, USA 289–299 (1998).
  • Andrykowski MA. Psychosocial factors in bone marrow transplantation: a review and recommendations for research. Bone Marrow 7iamplant. 13(4), 357–375 (1994).
  • Baker E Psychosocial sequelae of bone marrow transplantation. Oncology (Huntingt) 8(10), 87–92,97(1994).
  • Whedon M, Ferrell BR. QoL in adult bone marrow transplant patients: Beyond the first year. Semin. Oncol NUIN. 10(1), 42–57 (1994).
  • Curran D, Bacchi M, Schmitz SF, Molenberghs G, Sylvester RJ. Identifying the types of missingness in QoL data from clinical trials. Stat. Merl 17 (5–7), 739–756 (1998).
  • Fairclough DL, Peterson HF, Chang V Why are missing QoL data a problem in clinical trials of cancer therapy? Stat. Med17(5-7), 667–677 (1998).
  • van Agthoven M, Vellenga E, Fibbe WE, Kingma T, Uyl-de Groot CA. Cost analysis and QoL assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non- Hodgkin's lymphoma or Hodgkin's disease, a prospective randomised trial. Eur. Cancer 37 (14), 1781–1789 (2001).
  • •Interesting study comparing ASCT with ABMT on a number of parameters including QoL, engraftment, hospital events and costs.
  • Vellenga E, van Agthoven M, Croockewit AJ et al Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved QoL and cost reduction compared with bone marrow transplantation: the Hovon 22 study. Br Thematol 114(2), 319–326 (2001).
  • Shum N. Hypnosis in the management of pain of oral mucositis associated with high dose therapy for cancer. Aust. J. Clin. Exp. Hypnosis24(2), 120–124 (1996).
  • Gabriel B, Bromberg E, Vandenbovenkamp J, Walka P, Kornblith AB, Luzzatto P Art therapy with adult bone marrow transplant patients in isolation: a pilot study. Bychooncology10(2), 114–123 (2001).
  • Lane MT, Graham-Pole J. Development of an art program on a bone marrow transplant unit. Cancer Nurs. 17(3), 185–192 (1994).
  • Perry D. Psychological and social preparation for bone marrow transplantation. Soc. Work Health Care 30(4), 71–92 (2000).
  • De Luca A, M. Psychotherapy in early phases of oncological disease: A study of allogenic bone marrow transplanted patients. N Trends Exp. Clin. Psychiatry 14(1), 41–49 (1998).
  • DuHamel KN. Trauma-focused intervention after bone marrow transplantation: A case study. Behavior Ther. 31,175–186 (2000).
  • Foerster K. Supportive psychotherapy combined with autogenous training in acute leukemic patients with isolation therapy. Psychother. PTchosom. 41(2), 100–105 (1984).
  • Syrjala KL, Donaldson GW, Davis MW, Kippes ME, Carr JE. Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial. Pain 63(2), 189–198 (1995).
  • ••Intervention study comparing the efficacyof four interventions to help patients cope while hospitalized for BMT.
  • Molassiotis A, Van Den Akker OB, Milligan DW, Goldman JM. Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation. I Rychosomatic Res. 42(3), 275–285 (1997).
  • Mounier N, Haioun C, Cole BF et al QoL-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA) . Blood 95 (12), 3687–3692 (2000) .
  • •Study using the QTWiST method to compare ASCT versus CT in lymphoma patients.
  • Simpson JSA, Carlson LE, Trew M. Impact of a Group Psychosocial Intervention on Healthcare Utilization by Breast Cancer Patients. Cancer Pract. 9(1), 19–26 (2001).
  • Hann DM, Jacobsen PB, Martin SC, Kronish LE, Azzarello LM, Fields KK. QoL following bone marrow transplantation for breast cancer: a comparative study. Bone Marrow Transplant. 19(3), 257–264 (1997).
  • Mundy EA, Blanchard EB, Cirenza E, Gargiulo J, Maloy B, Blanchard CG. Posttraumatic stress disorder in breast cancer patients following autologous bone marrow transplantation or conventional cancer treatments. Behaviour Res. Ther. 38(10), 1015–1027 (2000).
  • Mehta P, Rodrigue J, Nejame C, Gaa R, Wingard JR. Acquiescence to adjunctive experimental therapies may relate to psychological distress: pilot data from a bone marrow transplant center. Bone Marrow Transplant. 25(6), 673–676 (2000).
  • Larsen J, Gardulf A, Nordstrom G, Bjorkstrand B, Ljungman P. Health-related QoL in women with breast cancer undergoing autologous stem-cell transplantation. Cancer Nuts. 19(5), 368–375 (1996).
  • Amato JJ, Williams M, Greenberg C, Bar M, Lo S, Tepler I. Psychological support to an autologous bone marrow transplant unit in a community hospital: a pilot experience. Psychooncology7 (2), 121–125 (1998).
  • Litwins NM, Rodrigue JR, Weiner RS. QoL in adult recipients of bone marrow transplantation. PTchol Rep. 75(1 Pt 1), 323–328 (1994).
  • Hjermstad MJ, Holte H, Evensen SA, Niers PM, Kaasa S. Do patients who are treated with stem cell transplantation have a health-related QoL comparable to the general popluation after 1 year? Bone Marrow Transplant. 24,911-918 (1999).
  • Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support. Care Cancer8(1), 33–39 (2000).
  • Saleh US, Brockopp DY. Hope among patients with cancer hospitalized for bone marrow transplantation: a phenomenologic study. Cancer Nuts. 24(4), 308–314 (2001).
  • Chao NJ, Tierney DK, Bloom JR et al Dynamic assessment of QoL after autologous bone marrow transplantation. B/ooc/80(3), 825–830 (1992).
  • Summers N, Dawe U, Stewart DA. A comparison of in-patient and out-patient ASCT. Bone Marrow Transplant. 26(4), 389–395 (2000).
  • Hjermstad MJ, Evenson SA, Kvaloy SO, Fayers PM, Kaasa S. Health-related QoL 1 year after allogeneic or autologous stem-cell transplantation: A prospective study.j Clin. Onco1.17 (2), 706–718 (1999).
  • Baker F, Zabora J, Polland A, Wingard J. Reintegration after bone marrow transplantation. Cancer Pract.7 (4), 190–197 (1999).
  • •Descriptive qualitative study looking at problems patients encounter in long-term recovery and reintigration.
  • Sullivan AK, Szkrumelak N, Hoffman LH. Psychological risk factors and early complications after bone marrow transplantation in adults. Bone Marrow Transplant. 24(10), 1109–1120 (1999).
  • •Intriguing paper looking at the predictive value of a composite measure of psychological functioning on survival in mixed auto and allo patients.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.